Pancreatic cancer exosomes: Their role in drug resistance and immunomodulation
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) has a low survival rate, which is primarily attributed to its aggressive metastatic potential, poor prognosis, and the rapid development of resistance to conventional therapies. Within the PDAC microenvironment (PDAC-ME)... ...
